5-HT neuroendocrine responses during psychotropic drug treatment: an investigation of the effects of lithium

Nils C. Gassen, Jakob Hartmann, Anthony S. Zannas, Anja Kretzschmar, Jürgen Zschocke, Giuseppina Maccarrone, Kathrin Hafner, Andreas Zellner, Lorenz Korbinian Kollmannsberger, Klaus V. Wagner, Divya Mehta, Stefan Kloiber, Christoph W. Turck, Susanne Lucae, George Chrousos, Herta Flor, Elisabeth B. Binder, Marcus Ising, Mathias V. Schmidt, Theo Rein

5-HT neuroendocrine responses during psychotropic drug treatment: an investigation of the effects of lithium

Discussion(0)

Related publications

THE NEGATIVE IMMUNOREGULATORY EFFECTS OF SEROTONIN (5-HT) MODULINE, AN ENDOGENOUS 5-HT1B RECEPTOR ANTAGONIST WITH ANTI-ANXIETY PROPERTIES

Functional characterization of a 5‐HT<sub>3</sub> receptor which modulates the release of 5‐HT in the guinea‐pig brain

Role of the terminal 5-HT autoreceptor in the orbitofrontal cortex in the mechanism of action of 5-HT reuptake inhibitors in obsessive compulsive disorder

Effects of Food Deprivation on Midbrain 5-HT 1A Autoreceptors in Lewis and SHR Rats

FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications